不含抗氧化剂的约氏乳杆菌La1不会降低四氯化碳诱导的肝硬化大鼠的细菌移位。 - Suppr

Suppr

超能文献

Lactobacillus johnsonii La1 without antioxidants does not decrease bacterial translocation in rats with carbon tetrachloride-induced cirrhosis.

作者信息

Soriano Germán, Sánchez Elisabet, Guarner Carlos, Schiffrin Eduardo J

出版信息

J Hepatol. 2012 Dec;57(6):1395-6. doi: 10.1016/j.jhep.2012.07.019. Epub 2012 Jul 20.

DOI:10.1016/j.jhep.2012.07.019

PMID:22824820

Abstract

摘要

相似文献

Lactobacillus johnsonii La1 without antioxidants does not decrease bacterial translocation in rats with carbon tetrachloride-induced cirrhosis.不含抗氧化剂的约氏乳杆菌La1不会降低四氯化碳诱导的肝硬化大鼠的细菌移位。

J Hepatol. 2012 Dec;57(6):1395-6. doi: 10.1016/j.jhep.2012.07.019. Epub 2012 Jul 20.

Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis.约氏乳杆菌La1与抗氧化剂对实验性肝硬化大鼠肠道菌群及细菌移位的影响

J Hepatol. 2002 Oct;37(4):456-62. doi: 10.1016/s0168-8278(02)00142-3.

Intestinal flora imbalance results in altered bacterial translocation and liver function in rats with experimental cirrhosis.实验性肝硬化大鼠肠道菌群失衡导致细菌易位和肝功能改变。

Eur J Gastroenterol Hepatol. 2010 Dec;22(12):1481-6. doi: 10.1097/MEG.0b013e32833eb8b0.

VSL#3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride-induced cirrhosis.VSL#3 益生菌治疗可降低四氯化碳诱导肝硬化大鼠的细菌易位。

Liver Int. 2015 Mar;35(3):735-45. doi: 10.1111/liv.12566. Epub 2014 May 12.

Fermented milk containing Lactobacillus paracasei subsp. paracasei CNCM I-1518 reduces bacterial translocation in rats treated with carbon tetrachloride.含有副干酪乳杆菌亚种副干酪乳杆菌 CNCM I-1518 的发酵乳可减少四氯化碳处理大鼠的细菌易位。

Sci Rep. 2017 Apr 3;7:45712. doi: 10.1038/srep45712.

Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites.普萘洛尔对腹水型肝硬化大鼠肠道细菌易位相关促进因素的影响。

Hepatology. 2000 Jan;31(1):43-8. doi: 10.1002/hep.510310109.

Bacterial translocation is downregulated by anti-TNF-alpha monoclonal antibody administration in rats with cirrhosis and ascites.在肝硬化腹水大鼠中，抗TNF-α单克隆抗体给药可下调细菌移位。

J Hepatol. 2007 May;46(5):797-803. doi: 10.1016/j.jhep.2006.11.018. Epub 2006 Dec 27.

Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats.胰岛素样生长因子I改善肝硬化大鼠的肠道屏障功能。

Gut. 2006 Sep;55(9):1306-12. doi: 10.1136/gut.2005.079988. Epub 2006 Jan 24.

Intestinal microbiota and innate immunity-related gene alteration in cirrhotic rats with liver transplantation.肝移植肝硬化大鼠肠道微生物群与先天免疫相关基因改变

Transplant Proc. 2011 Dec;43(10):3973-9. doi: 10.1016/j.transproceed.2011.08.113.

Norfloxacin is more effective than Rifaximin in avoiding bacterial translocation in an animal model of cirrhosis.诺氟沙星在避免肝硬化动物模型中的细菌易位方面比利福昔明更有效。

Liver Int. 2018 Feb;38(2):295-302. doi: 10.1111/liv.13551. Epub 2017 Sep 13.

引用本文的文献

Unveiling the potential of in digestive diseases: a comprehensive review.揭示[具体内容]在消化系统疾病中的潜力：一项综述。（注：原文中“in digestive diseases”前缺失具体所指内容）

Front Microbiol. 2025 Aug 1;16:1508382. doi: 10.3389/fmicb.2025.1508382. eCollection 2025.

Gut microbiome-brain-cirrhosis axis.肠道微生物群-肝硬化轴。

Hepatology. 2024 Aug 1;80(2):465-485. doi: 10.1097/HEP.0000000000000344. Epub 2023 Mar 6.

6084 alleviated sepsis-induced organ injury by modulating gut microbiota.6084 通过调节肠道微生物群减轻败血症诱导的器官损伤。

Food Sci Nutr. 2022 Jul 22;10(11):3931-3941. doi: 10.1002/fsn3.2989. eCollection 2022 Nov.

Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches.肠道微生物群和氧化应激在非酒精性脂肪性肝病向肝癌进展中的作用：当前和创新的治疗方法。

Redox Biol. 2018 May;15:467-479. doi: 10.1016/j.redox.2018.01.009. Epub 2018 Feb 3.

Probiotic Mixture Golden Bifido Prevents Neonatal K1 Translocation via Enhancing Intestinal Defense.益生菌混合物金双歧通过增强肠道防御预防新生儿 K1 移位。

Front Microbiol. 2017 Sep 20;8:1798. doi: 10.3389/fmicb.2017.01798. eCollection 2017.

Sci Rep. 2017 Apr 3;7:45712. doi: 10.1038/srep45712.

Non-alcoholic fatty liver disease, diet and gut microbiota.非酒精性脂肪性肝病、饮食与肠道微生物群

EXCLI J. 2014 May 7;13:461-90. eCollection 2014.

Gut microbiota-related complications in cirrhosis.肝硬化中与肠道微生物群相关的并发症。

World J Gastroenterol. 2014 Nov 14;20(42):15624-31. doi: 10.3748/wjg.v20.i42.15624.

Oral administration of Saccharomyces boulardii ameliorates carbon tetrachloride-induced liver fibrosis in rats via reducing intestinal permeability and modulating gut microbial composition.口服布拉氏酵母菌可通过降低肠道通透性和调节肠道微生物组成来改善大鼠四氯化碳诱导的肝纤维化。

Inflammation. 2015 Feb;38(1):170-9. doi: 10.1007/s10753-014-0019-7.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验